Title : Meeting the needs of CML patients in resource-poor countries.

Pub. Date : 2019 Dec 6

PMID : 31808889






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Subsequent to the development and global availability of BCR/ABL-targeted tyrosine kinase inhibitors (TKIs), the prognosis of patients with chronic myeloid leukemia (CML), at least those in the chronic phase, has markedly improved, and in the developed world, the average lifespan of these patients is now close to that of age- and sex-matched subjects without the disease. Tyrosine ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens